Liver injury in COVID-19: management and challenges

Chao Zhang; Lei Shi; Fu-Sheng Wang

doi:10.1016/s2468-1253(20)30057-1

journal article May 01, 2020

Liver injury in COVID-19: management and challenges

Chao Zhang

Lei Shi

Fu-Sheng Wang

The Lancet Gastroenterology & Hepatology Vol. 5 No. 5 pp. 428-430 · Elsevier BV

View at Publisher Save 10.1016/s2468-1253(20)30057-1

Topics

No keywords indexed for this article. Browse by subject →

References

13

[1]

Clinical Characteristics of Coronavirus Disease 2019 in China

Wei-jie Guan, Zheng-yi Ni, Yu Hu et al.

New England Journal of Medicine 2020 10.1056/nejmoa2002032

[2]

Wang "What to do next to control the 2019-nCoV epidemic?" Lancet (2020) 10.1016/s0140-6736(20)30300-7

[3]

Chau "SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases" Hepatology (2004) 10.1002/hep.20111

[4]

Alsaad "Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection—clinicopathological and ultrastructural study" Histopathology (2018) 10.1111/his.13379

[5]

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang, Yeming Wang, Xingwang Li et al.

The Lancet 2020 10.1016/s0140-6736(20)30183-5

[6]

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Nanshan Chen, Min Zhou, Xuan Dong et al.

The Lancet 2020 10.1016/s0140-6736(20)30211-7

[7]

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

Dawei Wang, Bo Hu, Chang Hu et al.

JAMA 2020 10.1001/jama.2020.1585

[8]

Shi "Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study" Lancet Infect Dis (2020) 10.1016/s1473-3099(20)30086-4

[9]

Xu "Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series" BMJ (2020) 10.1136/bmj.m606

[10]

Yang "Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study" Lancet Respir Med (2020) 10.1016/s2213-2600(20)30079-5

[11]

Yeo "Enteric involvement of coronaviruses: is faecal–oral transmission of SARS-CoV-2 possible?" Lancet Gastroenterol Hepatol (2020) 10.1016/s2468-1253(20)30048-0

[12]

Chai "Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection" bioRxiv (2020)

[13]

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Zhe Xu, Lei Shi, Yijin Wang et al.

The Lancet Respiratory Medicine 2020 10.1016/s2213-2600(20)30076-x

Cited By

1,437

Association of Altered Plasma Lipidome with Disease Severity in COVID-19 Patients

Zhengzheng Zhang, Naama Karu · 2024

Biomolecules

Modeling SARS-CoV-2 and HBV co-dynamics with optimal control

Andrew Omame, Mujahid Abbas · 2023

Physica A: Statistical Mechanics an...

Long COVID: pathophysiological factors and abnormalities of coagulation

Simone Turner, M. Asad Khan · 2023

Trends in Endocrinology & Metab...

Development of a targeted hydrophilic interaction liquid chromatography-tandem mass spectrometry based lipidomics platform applied to a coronavirus disease severity study

Zhengzheng Zhang, Madhulika Singh · 2023

Journal of Chromatography A

A stochastic stability analysis of an HBV–COVID-19 co-infection model in resource limitation settings

Anwarud Din, Yongjin Li · 2022

Waves in Random and Complex Media

Exploring the possible molecular targeting mechanism of Saussurea involucrata in the treatment of COVID-19 based on bioinformatics and network pharmacology

Dongdong Zhang, Zhaoye Wang · 2022

Computers in Biology and Medicine

Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study

Seong Hee Kang, Dong-Hyuk Cho · 2021

PLoS ONE

Humoral immune mechanisms involved in protective and pathological immunity during COVID-19

Gunawan Widjaja, Abduladheem Turki Jalil · 2021

Human Immunology

COVID-19 and the liver: A brief and core review

Bircan Kayaaslan, Rahmet Guner · 2021

World Journal of Hepatology

Severe acute respiratory syndrome coronavirus 2 (SARS‐COV‐2) /Hepatitis B virus (HBV) Co‐infected Patients: A case series and review of the literature

Muhammed Bekçibaşı, Eyüp Arslan · 2021

International Journal of Clinical P...

Interaction between hepatitis B virus and SARS-CoV-2 infections

Tian-Dan Xiang, Xin Zheng · 2021

World Journal of Gastroenterology

Characteristics of Liver Function in Patients With SARS-CoV-2 and Chronic HBV Coinfection

Xiaojing Zou, Minghao Fang · 2021

Clinical Gastroenterology and Hepat...

Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates

Shuyu Shou, Menghui Liu · 2021

Frontiers in Microbiology

Artificial Intelligence in Surveillance, Diagnosis, Drug Discovery and Vaccine Development against COVID-19

Gunjan Arora, Jayadev Joshi · 2021

Pathogens

Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19

Vincent L. Chen, Fadi Hawa · 2020

Digestive Diseases and Sciences

Extrapulmonary manifestations of COVID-19

Aakriti Gupta, Mahesh V. Madhavan · 2020

Nature Medicine

Epidemiological and clinical characteristics of 70 cases of coronavirus disease and concomitant hepatitis B virus infection: A multicentre descriptive study

Jian Wu, Jihong Yu · 2020

Journal of Viral Hepatitis

Use of SARS-CoV-2-infected deceased organ donors: Should we always “just say no?”

Olivia S. Kates, Cynthia E. Fisher · 2020

American Journal of Transplantation

COVID-19: Specific and Non-Specific Clinical Manifestations and Symptoms: The Current State of Knowledge

Jacek Baj, Hanna Karakuła-Juchnowicz · 2020

Journal of Clinical Medicine

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

Tobias Boettler, Philip N. Newsome · 2020

JHEP Reports

Metrics

1,437

Citations

13

References

Details

Published: May 01, 2020
Vol/Issue: 5(5)
Pages: 428-430
License: View

Authors

C

Chao Zhang

Department of Chemistry and E. O. Lawrence Berkeley National Laboratory, University of California, Berkeley, CA 94720

Cite This Article

Chao Zhang, Lei Shi, Fu-Sheng Wang (2020). Liver injury in COVID-19: management and challenges. The Lancet Gastroenterology & Hepatology, 5(5), 428-430. https://doi.org/10.1016/s2468-1253(20)30057-1

Liver injury in COVID-19: management and challenges

You May Also Like